1(OH) Vitamin D3 Supplementation Improves the Sensitivity of the Immune-Response during Peg-IFN/RBV Therapy in Chronic Hepatitis C Patients-Case Controlled Trial

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Kondo, Yasuteru ^a   Kato, Takanobu ^b   Kimura, Osamu ^a   Iwata, Tomoaki ^a   Ninomiya, Masashi ^a   Kakazu, Eiji ^a   Miura, Masahito ^c   Akahane, Takehiro ^d   Miyazaki, Yutaka ^e   Kobayashi, Tomoo ^f   Ishii, Motoyasu ^g   Kisara, Norihiro ^g   Sasaki, Kumiko ^g   Nakayama, Haruo ^h   Igarashi, Takehiko ^h   Obara, Noriyuki ⁱ   Ueno, Yoshiyuki ^j   Morosawa, Tatsuki ^a   Shimosegawa, Tooru ^a  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c South Miyagi Medical Center   (Japan)

^d Ishinomiki Red Cross Hospital   (Japan)

^e Department of Gastroenterology   (Japan)

^f Rosai Hospital   (Japan)

^g Department of Gastroenterology   (Japan)

^h Iwaki Kyoritsu Hosptal ^*  (Japan)

ⁱ IWATE PREFECTURAL CENTRAL HOSPITAL   (Japan)

^j YAMAGATA UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PEGINTERFERON; RANTES; RIBAVIRIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CELL ACTIVITY; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; FEMALE; GENE; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; HEPATITIS C; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; IMMUNE RESPONSE; INTERFERON STIMULATED GENE; KIDNEY FAILURE; LIVER BIOPSY; MALE; MULTICENTER STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN DETERMINATION; REAL TIME POLYMERASE CHAIN REACTION; TH1 CELL; TREATMENT RESPONSE; VITAMIN SUPPLEMENTATION;

ADULT; AGED; ANTIVIRAL AGENTS; CALCIFEDIOL; CELL LINE, TUMOR; CYTOKINES; DIETARY SUPPLEMENTS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; GENE EXPRESSION; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC FACTORS; INTERFERON-ALPHA; LIVER; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RIBAVIRIN; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TREATMENT OUTCOME;

EID: 84878156596     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063672     Document Type: Article

References (42)

1. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, et al. (1999) The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341: 556-562.
2. Abu-Mouch S, Fireman Z, Jarchovsky J, Zeina AR, Assy N, (2011) Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naive patients. World J Gastroenterol 17: 5184-5190.
3. Bitetto D, Fabris C, Fornasiere E, Pipan C, Fumolo E, et al. (2011) Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C. Transpl Int. 24: 43-50.
4. Bitetto D, Fattovich G, Fabris C, Ceriani E, Falleti E, et al. (2011) Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C. Hepatology. 53: 1118-1126.
5. Petta S, Ferraro D, Camma C, Cabibi D, Di Cristina A, et al. (2012) Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. Antiviral therapy. 17: 823-831.
6. Gal-Tanamy M, Bachmetov L, Ravid A, Koren R, Erman A, et al. (2011) Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes. Hepatology 54: 1570-1579.
7. Matsumura T, Kato T, Sugiyama N, Tasaka-Fujita M, Murayama A, et al. (2012) 25-hydroxyvitamin D(3) suppresses hepatitis C virus production. Hepatology.
8. Haddad JG, Matsuoka LY, Hollis BW, Hu YZ, Wortsman J, (1993) Human plasma transport of vitamin D after its endogenous synthesis. The Journal of clinical investigation 91: 2552-2555.
9. DeLuca HF, (1977) Regulation of vitamin D metabolism in the kidney. Advances in experimental medicine and biology 81: 195-209.
10. Deluca HF, (1977) Vitamin D metabolism. Clinical endocrinology 7Suppl: 1s-17s.
11. DeLuca HF, (1977) Vitamin D endocrine system. Advances in clinical chemistry 19: 125-174.
12. Edfeldt K, Liu PT, Chun R, Fabri M, Schenk M, et al. (2010) T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci U S A 107: 22593-22598.
13. Bartosik-Psujek H, Tabarkiewicz J, Pocinska K, Stelmasiak Z, Rolinski J, (2010) Immunomodulatory effects of vitamin D on monocyte-derived dendritic cells in multiple sclerosis. Mult Scler 16: 1513-1516.
14. Du T, Zhou ZG, You S, Lin J, Yang L, et al. (2009) Regulation by 1, 25-dihydroxy-vitamin D3 on altered TLRs expression and response to ligands of monocyte from autoimmune diabetes. Clin Chim Acta 402: 133-138.
15. Stio M, Treves C, Celli A, Tarantino O, d'Albasio G, et al. (2002) Synergistic inhibitory effect of cyclosporin A and vitamin D derivatives on T-lymphocyte proliferation in active ulcerative colitis. Am J Gastroenterol 97: 679-689.
16. Takahashi K, Nakayama Y, Horiuchi H, Ohta T, Komoriya K, et al. (2002) Human neutrophils express messenger RNA of vitamin D receptor and respond to 1alpha,25-dihydroxyvitamin D3. Immunopharmacology and immunotoxicology 24: 335-347.
17. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC, (1983) 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 221: 1181-1183.
18. Xu H, Soruri A, Gieseler RK, Peters JH, (1993) 1,25-Dihydroxyvitamin D3 exerts opposing effects to IL-4 on MHC class-II antigen expression, accessory activity, and phagocytosis of human monocytes. Scandinavian journal of immunology 38: 535-540.
19. Piemonti L, Monti P, Sironi M, Fraticelli P, Leone BE, et al. (2000) Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. Journal of immunology 164: 4443-4451.
20. Hewison M, Freeman L, Hughes SV, Evans KN, Bland R, et al. (2003) Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 170: 5382-5390.
21. Khoo AL, Joosten I, Michels M, Woestenenk R, Preijers F, et al. (2011) 1,25-Dihydroxyvitamin D3 inhibits proliferation but not the suppressive function of regulatory T cells in the absence of antigen-presenting cells. Immunology 134: 459-468.
22. Khoo AL, Chai LY, Koenen HJ, Sweep FC, Joosten I, et al. (2011) Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals. Clin Exp Immunol 164: 72-79.
23. Unger WW, Laban S, Kleijwegt FS, van der Slik AR, Roep BO, (2009) Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. Eur J Immunol 39: 3147-3159.
24. Mariani E, Ravaglia G, Forti P, Meneghetti A, Tarozzi A, et al. (1999) Vitamin D, thyroid hormones and muscle mass influence natural killer (NK) innate immunity in healthy nonagenarians and centenarians. Clin Exp Immunol 116: 19-27.
25. Mayne CG, Spanier JA, Relland LM, Williams CB, Hayes CE, (2011) 1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis. Eur J Immunol 41: 822-832.
26. Barchetta I, Carotti S, Labbadia G, Gentilucci UV, Muda AO, et al. (2012) Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus. Hepatology 56: 2180-2187.
27. Abu-Mouch SM, Fireman Z, Jarchovsky J, Assy N, (2009) The Beneficial Effect of Vitamin D with Combined Peg Interferon and Ribavirin for Chronic Hcv Infection. Hepatology 50: 12A-13A.
28. Kakazu E, Ueno Y, Kondo Y, Fukushima K, Shiina M, et al. (2009) Branched chain amino acids enhance the maturation and function of myeloid dendritic cells ex vivo in patients with advanced cirrhosis. Hepatology 50: 1936-1945.
29. Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, et al. (2009) Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet. 41: 1105-1109.
30. Honda M, Sakai A, Yamashita T, Nakamoto Y, Mizukoshi E, et al. (2010) Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. Gastroenterology. 139: 499-509.
31. Nimer A, Mouch A, (2012) Vitamin D improves viral response in hepatitis C genotype 2-3 naive patients. World J Gastroenterol 18: 800-805.
32. Kondo Y, Ueno Y, Kakazu E, Kobayashi K, Shiina M, et al. (2011) Lymphotropic HCV strain can infect human primary naive CD4+ cells and affect their proliferation and IFN-gamma secretion activity. J Gastroenterol 46: 232-241.
33. Kondo Y, Machida K, Liu HM, Ueno Y, Kobayashi K, et al. (2009) Hepatitis C virus infection of T cells inhibits proliferation and enhances fas-mediated apoptosis by down-regulating the expression of CD44 splicing variant 6. J Infect Dis 199: 726-736.
34. Machida K, Kondo Y, Huang JY, Chen YC, Cheng KT, et al. (2008) Hepatitis C virus (HCV)-induced immunoglobulin hypermutation reduces the affinity and neutralizing activities of antibodies against HCV envelope protein. J Virol 82: 6711-6720.
35. Kondo Y, Sung VM, Machida K, Liu M, Lai MM, (2007) Hepatitis C virus infects T cells and affects interferon-gamma signaling in T cell lines. Virology 361: 161-173.
36. Fattovich G, Covolo L, Bibert S, Askarieh G, Lagging M, et al. (2011) IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C. Aliment Pharmacol Ther. 33: 1162-1172.
37. Darling JM, Aerssens J, Fanning G, McHutchison JG, Goldstein DB, et al. (2011) Quantitation of pretreatment serum interferon-gamma-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response. Hepatology 53: 14-22.
38. Dill MT, Duong FH, Vogt JE, Bibert S, Bochud PY, et al. (2011) Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C. Gastroenterology. 140: 1021-1031.
39. Abe H, Hayes CN, Ochi H, Maekawa T, Tsuge M, et al. (2011) IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy. J Hepatol 54: 1094-1101.
40. Schaalan MF, Mohamed WA, Amin HH, (2012) Vitamin D deficiency: Correlation to interleukin-17, interleukin-23 and PIIINP in hepatitis C virus genotype 4. World J Gastroenterol 18: 3738-3744.
41. Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, et al. (2006) Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 36: 361-370.
42. Aarskog NK, Vedeler CA, (2000) Real-time quantitative polymerase chain reaction. A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies. Human genetics 107: 494-498.